These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 31000801)

  • 1. Opportunities and challenges using artificial intelligence in ADME/Tox.
    Bhhatarai B; Walters WP; Hop CECA; Lanza G; Ekins S
    Nat Mater; 2019 May; 18(5):418-422. PubMed ID: 31000801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning in Drug Discovery.
    Gawehn E; Hiss JA; Schneider G
    Mol Inform; 2016 Jan; 35(1):3-14. PubMed ID: 27491648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting machine learning for end-to-end drug discovery and development.
    Ekins S; Puhl AC; Zorn KM; Lane TR; Russo DP; Klein JJ; Hickey AJ; Clark AM
    Nat Mater; 2019 May; 18(5):435-441. PubMed ID: 31000803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected Papers from the Workshop on Computational Biology: Joint with the International Joint Conference on Artificial Intelligence and the International Conference on Machine Learning, 2018.
    Diallo AB; Nguifo EM; Dhifli W; Azizi E; Prabhakaran S; Tansey W
    J Comput Biol; 2019 Jun; 26(6):507-508. PubMed ID: 31184954
    [No Abstract]   [Full Text] [Related]  

  • 8. Machine Learning and Deep Learning in Medical Imaging: Intelligent Imaging.
    Currie G; Hawk KE; Rohren E; Vial A; Klein R
    J Med Imaging Radiat Sci; 2019 Dec; 50(4):477-487. PubMed ID: 31601480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenges of generalizability in artificial intelligence for ADME/Tox endpoint and activity prediction.
    Huang DZ; Baber JC; Bahmanyar SS
    Expert Opin Drug Discov; 2021 Sep; 16(9):1045-1056. PubMed ID: 33739897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Artificial Intelligence-Powered New Era in Pharmaceutical Research and Development: A Review.
    Suriyaamporn P; Pamornpathomkul B; Patrojanasophon P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    AAPS PharmSciTech; 2024 Aug; 25(6):188. PubMed ID: 39147952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Target Prediction for Small Molecules.
    Byrne R; Schneider G
    Methods Mol Biol; 2019; 1888():273-309. PubMed ID: 30519953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
    Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
    Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine and deep learning approaches for cancer drug repurposing.
    Issa NT; Stathias V; Schürer S; Dakshanamurthy S
    Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery.
    Bhatia AS; Saggi MK; Kais S
    J Chem Inf Model; 2023 Nov; 63(21):6476-6486. PubMed ID: 37603536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico technologies in drug design, discovery and development.
    Zhang YJ
    Curr Top Med Chem; 2010; 10(6):617-8. PubMed ID: 20374192
    [No Abstract]   [Full Text] [Related]  

  • 16. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geometric Deep Learning Autonomously Learns Chemical Features That Outperform Those Engineered by Domain Experts.
    Hop P; Allgood B; Yu J
    Mol Pharm; 2018 Oct; 15(10):4371-4377. PubMed ID: 29863875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-Generation Machine Learning for Biological Networks.
    Camacho DM; Collins KM; Powers RK; Costello JC; Collins JJ
    Cell; 2018 Jun; 173(7):1581-1592. PubMed ID: 29887378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning in Virtual Screening: Recent Applications and Developments.
    Kimber TB; Chen Y; Volkamer A
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
    Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
    J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.